Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ganchimeg Ishdorj, Lin Li & Spencer B. Gibson. (2012) Regulation of autophagy in hematological malignancies: role of reactive oxygen species. Leukemia & Lymphoma 53:1, pages 26-33.
Read now
Read now
Shahab Uddin & Khawla S. Al-Kuraya. (2011) Localization of death receptor 4 in lipid rafts sensitizes chronic lymphocytic leukemia to chemotherapeutic drug mediated apoptosis. Leukemia & Lymphoma 52:7, pages 1176-1177.
Read now
Read now
Wenyan Xiao, Ganchimeg Ishdorj, Jinmei Sun, James B. Johnston & Spencer B. Gibson. (2011) Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses. Leukemia & Lymphoma 52:7, pages 1290-1301.
Read now
Read now
D Ross Camidge. (2008) Apomab: An agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors. Expert Opinion on Biological Therapy 8:8, pages 1167-1176.
Read now
Read now
Articles from other publishers (32)
Mervat Khorshied, Nohair Soliman, Ola Khorshid & Salwa Bakr. (2022) Genetic variations in tumor necrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt1. Cancer Biomarkers 32:4, pages 451-458.
Crossref
Crossref
Shahira Amin Zayed, Nariman M. Zahran, Mervat Mamdooh Khorshied, Ashraf Omar Abdel‐Aziz, Ola Mahmoud, Shereif Ahmed Morsy, Hend Ibrahim Shousha, Tamer Mahmoud Elbaz, Mohamed Mahmoud Nabeel & Amira Ramadan Korany Harb. (2019) Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma. Journal of Medical Virology 91:8, pages 1537-1544.
Crossref
Crossref
Jung Soon Hwang, Yong Yook Lee, Dae-Hee Lee & Ki Han Kwon. (2017) DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS. Food and Chemical Toxicology 106, pages 514-521.
Crossref
Crossref
Mohammed Elmallah, Olivier Micheau, Mennat Allah Eid, Ali Hebishy & Mohamed Abdelfattah. (2017) Marine actinomycete crude extracts with potent TRAIL-resistance overcoming activity against breast cancer cells. Oncology Reports.
Crossref
Crossref
A Fassl, K E Tagscherer, J Richter, J De-Castro Arce, C Savini, F Rösl & W Roth. (2015) Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5. Cell Death & Disease 6:10, pages e1921-e1921.
Crossref
Crossref
Rama D. Mittal, Raju K. Mandal, Abhinav Singh & Priyanka Srivastava. (2015) Death receptor 4 variants enhanced prostate cancer risk in North Indian population. Tumor Biology 36:7, pages 5655-5661.
Crossref
Crossref
Dae-Hee Lee, Dong-Wook Kim, Hai-Chon Lee, Jung-Hyun Lee & Tae-Hwa Lee. (2014) Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis. Biochemical and Biophysical Research Communications 446:4, pages 815-821.
Crossref
Crossref
Ju-Yoon Yoon, Ganchimeg Ishdorj, Bonnie A. Graham, James B. Johnston & Spencer B. Gibson. (2013) Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells. Apoptosis 19:1, pages 191-200.
Crossref
Crossref
T R Burton, E S Henson, M B Azad, M Brown, D D Eisenstat & S B Gibson. (2013) BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas. Cell Death & Disease 4:4, pages e587-e587.
Crossref
Crossref
Ying Huang. (2012) The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in�vivo. International Journal of Molecular Medicine.
Crossref
Crossref
Alan S. Wayne. 2013. Childhood Leukemias. Childhood Leukemias
563
581
.
Yanli Niu, Yongqiang Li, Jianfeng Zang, Hongen Huang, Jiexin Deng, Zhanjun Cui, Dongming Yu & Jinbo Deng. (2011) Death Receptor 5 and Neuroproliferation. Cellular and Molecular Neurobiology 32:2, pages 255-265.
Crossref
Crossref
Versha Banerji & Spencer B. Gibson. (2012) Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies. International Journal of Cell Biology 2012, pages 1-9.
Crossref
Crossref
Courtney M. Shirley, Jianmeng Chen, Meir Shamay, Huili Li, Cynthia A. Zahnow, S. Diane Hayward & Richard F. Ambinder. (2011) Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood 117:23, pages 6297-6303.
Crossref
Crossref
Jing OuyangPrzemyslaw JuszczynskiScott J. RodigMichael R. GreenEvan O'DonnellTreeve CurrieMyriam ArmantKunihiko TakeyamaStefano Monti, Gabriel A. Rabinovich, Jerome RitzJeffery L. KutokMargaret A. Shipp. (2011) Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders. Blood 117:16, pages 4315-4322.
Crossref
Crossref
Tomoyo Kawakubo, Atsushi Yasukochi, Seiji Nakamura & Kenji Yamamoto. (2011) Cathepsin E as a Potent Anticancer Protease. Journal of Oral Biosciences 53:2, pages 128-136.
Crossref
Crossref
Jessica C. Shand, Johan Jansson, Yu-Chiao Hsu, Andrew Campbell & Craig A. Mullen. (2010) Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant. Cancer Immunology, Immunotherapy 59:11, pages 1633-1644.
Crossref
Crossref
Andre Ortlieb Guerreiro-Cacais, Jelena Levitskaya & Victor Levitsky. (2010) B cell receptor triggering sensitizes human B cells to TRAIL-induced apoptosis. Journal of Leukocyte Biology 88:5, pages 937-945.
Crossref
Crossref
K Mizrahi, J Stein, M Pearl-Yafe, O Kaplan, I Yaniv & N Askenasy. (2010) Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation. Leukemia 24:7, pages 1325-1334.
Crossref
Crossref
Changbao Chen, Hua Zhou, Lanjun Xu, Dong Xu, Ying Wang, Yingmei Zhang, Xiaoguang Liu, Zhongjun Liu, Dalong Ma, Qingjun Ma & Yingyu Chen. (2010) Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis 15:7, pages 805-813.
Crossref
Crossref
Mary K. Wilson, Sarah M. McWhirter, Rupesh H. Amin, Dan Huang & Mark S. Schlissel. (2010) Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-κB. Molecules and Cells 29:4, pages 333-341.
Crossref
Crossref
YanFang Wang, Lin Shi, QuanSheng Song, YingMei Zhang, YaXin Lou, Yi Zheng, DaLong Ma, Ying Wang & XiaoYan Ke. (2009) Recombinant human PDCD5 protein enhances chemosensitivities of hematologic malignancies. Chinese Science Bulletin 54:21, pages 3981-3989.
Crossref
Crossref
D.D. Cui, Y. Huang, S.H. Mao, S.C. Chen, M. Qiu, L.L. Ji & C. Yi. (2009) Synergistic antitumor effect of TRAIL and adriamycin on the human breast cancer cell line MCF-7. Brazilian Journal of Medical and Biological Research 42:9, pages 854-862.
Crossref
Crossref
Antònia Obrador-Hevia, Silvia Fernández de Mattos, Priam Villalonga & José Rodríguez. (2009) Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategies. Blood Reviews 23:5, pages 205-216.
Crossref
Crossref
K‐John J. Cheung, Douglas E. Horsman & Randy D. Gascoyne. (2009)
The significance of
TP53
in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target
. British Journal of Haematology 146:3, pages 257-269.
Crossref
Crossref
Gwendaline Guidicelli, Benjamin Chaigne-Delalande, Marie-Sarah Dilhuydy, Benoît Pinson, Walid Mahfouf, Jean-Max Pasquet, François-Xavier Mahon, Philippe Pourquier, Jean-François Moreau & Patrick Legembre. (2009) The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells. PLoS ONE 4:5, pages e5493.
Crossref
Crossref
Claudia Jursik, Michaela Prchal, Regina Grillari-Voglauer, Karel Drbal, Elke Fuertbauer, Herbert Jungfer, Winfried H. Albert, Eva Steinhuber, Thomas Hemetsberger, Johannes Grillari, Hannes Stockinger & Hermann Katinger. (2009) Large-Scale Production and Characterization of Novel CD4+ Cytotoxic T Cells with Broad Tumor Specificity for Immunotherapy. Molecular Cancer Research 7:3, pages 339-353.
Crossref
Crossref
Dafeng Yang, Suizhao Wang, Craig Brooks, Zheng Dong, Patricia V. Schoenlein, Vijay Kumar, Xinshou Ouyang, Huabao Xiong, Guy Lahat, Andrea Hayes-Jordan, Alexander Lazar, Raphael Pollock, Dina Lev & Kebin Liu. (2009) IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor–Initiated Apoptosis via Repression of FLICE-like Protein Expression. Cancer Research 69:3, pages 1080-1088.
Crossref
Crossref
Meilin Wang, Miaomiao Wang, Gong Cheng, Zhizhong Zhang, Guangbo Fu & Zhengdong Zhang. (2009) Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 661:1-2, pages 85-92.
Crossref
Crossref
Virginie Lamy, Stamatiki Roussi, Mehdi Chaabi, Francine Gossé, Annelise Lobstein & Francis Raul. (2008) Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells. Apoptosis 13:10, pages 1232-1242.
Crossref
Crossref
Nayoung Kim. (2009) Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL). Archives of Pharmacal Research 31:9, pages 1179-1186.
Crossref
Crossref
Martina Řezáčová, Jiřina Vávrová & Doris Vokurková. (2008) Ionizing Radiation Sensitizes Leukemic MOLT-4 Cells to TRAIL-induced Apoptosis. Acta Medica (Hradec Kralove, Czech Republic) 51:2, pages 101-105.
Crossref
Crossref